Does tirofiban improve safety and late survival in patients with acute moderate ischemic stroke?
Patients with acute moderate ischemic stroke
Tirofiban administered within a large time window after symptom onset
Safety and late survivalsafety
Tirofiban appears safe and may improve late survival in patients with acute moderate ischemic stroke, even with delayed administration.
We conclude that tirofiban might be safe in acute moderate ischemic stroke even when administered within a large time window after symptom onset and might save lives in the late outcome. Clinical Trial Registration- URL: www.strokecenter.org/trials/. Trial name: SaTIS. Enrollment began before July 1, 2005.
Building similarity graph...
Analyzing shared references across papers
Loading...
Mario Siebler
Michael G. Hennerici
Dietmar Schneider
Stroke
Leipzig University
Friedrich Schiller University Jena
Max Planck Institute for Human Cognitive and Brain Sciences
Building similarity graph...
Analyzing shared references across papers
Loading...
Siebler et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d56c6275589c71d767ce04 — DOI: https://doi.org/10.1161/strokeaha.110.599662